New Study Sheds Light on Long Covid Mechanisms

Research finds inflammation and immune system activation in long Covid patients, potentially opening doors for targeted treatments.

Long Covid may involve reactivation of dormant viruses like herpes, contributing to ongoing symptoms.
Inflammation patterns in blood of long Covid sufferers suggest possible treatment paths with existing drugs.
Trials into rheumatoid arthritis drug Tocilizumab show promise for treating long Covid, hinting at similarities with post-viral syndromes.
Distinct immune responses linked to different long Covid symptoms, pointing towards the need for personalized treatment approaches.
Largest UK study on hospitalized Covid-19 patients reveals tell-tale signs of long Covid in the blood, supporting the theory of active inflammation.